跳至主要内容
临床试验/IRCT138802171856N1
IRCT138802171856N1已完成2 期

A comparative study of the effects of low dose topiramate versus sodium valporate in migraine prophylaxis

Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • more than 4 and less than 10 attacks monthly, patient age at onset of headache less than 50 years, patient’s age between 18-65 years, discontinuation of other prophylactic drugs one month prior to study, interval between attacks more than 48 hours
  • Exclusion criteria: pregnancy and breast feeding, non-migraine headaches, overuse of medications in migraine attacks (consumption of NSAID, Ergots & Triptans more than 8 days a month), substance and alcohol abuse, illiteracy of patients and their family (unable to fill diaries)

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services

相似试验

comparison of topiramate and sodium valporate in... | 临床试验